![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Novo Nordisk |
Information provided by: | Novo Nordisk |
ClinicalTrials.gov Identifier: | NCT00600626 |
This trial is conducted in Europe and Asia.
The aim of this trial is to compare basal bolus treatment with insulin aspart and insulin NPH to biphasic insulin aspart treatment on blood glucose control in type 2 diabetes.
Condition | Intervention | Phase |
Diabetes Mellitus, Type 2 |
Drug: biphasic insulin aspart Drug: insulin NPH Drug: insulin aspart |
Phase IV |
MedlinePlus related topics: | Diabetes |
Drug Information available for: | Insulin Insulin aspart Insulin, isophane |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Comparison of Basal Bolus Treatment With Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes Mellitus |
Estimated Enrollment: | 395 |
Study Start Date: | January 2004 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Croatia | |||||
Zagreb, Croatia, 10 000 | |||||
France | |||||
LILLE, France, 59037 | |||||
Germany | |||||
Neuss, Germany, 41460 | |||||
Hong Kong | |||||
Hong Kong, Hong Kong | |||||
Malaysia, Kuala Lumpur | |||||
Cheras, Kuala Lumpur, Malaysia, 56000 | |||||
Netherlands | |||||
Beverwijk, Netherlands, 1942 LE | |||||
Poland | |||||
Lodz, Poland, 90-030 | |||||
Romania | |||||
Timisoara, Romania, 300736 | |||||
Russian Federation, Russia | |||||
St. Petersburg, Russia, Russian Federation, 194354 | |||||
Singapore | |||||
Singapore, Singapore, 119074 | |||||
Spain | |||||
Sevilla, Spain, 41009 | |||||
Sweden | |||||
Lund, Sweden, 221 85 | |||||
United Kingdom | |||||
York, United Kingdom, YO3 7HE |
Novo Nordisk |
Study Director: | Plamen Kozlovski | Novo Nordisk A/S |
Clinical Trials at Novo Nordisk 
![]()   |
Responsible Party: | Novo Nordisk A/S ( Public Access to Clinical Trials ) |
Study ID Numbers: | BIASP-1486 |
First Received: | January 14, 2008 |
Last Updated: | September 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00600626 |
Health Authority: | Croatia: Ministry of Health and Social Care; France: Afssaps - French Health Products Safety Agency; Germany: Federal Institute for Drugs and Medical Devices; Hong Kong: Department of Health; Malaysia: Ministry of Health; Netherlands: Dutch Health Care Inspectorate; Poland: The Office for Reg. of Medicinal Products, Medical Devices; Romania: State Institute for Drug Control; Russia: Federal Service for Control of Health Care and Social Developme; Singapore: Health Sciences Authority; Spain: Spanish Agency of Medicines; Sweden: Medical Products Agency; United Kingdom: Medicines and Healthcare Products Regulatory Agency |
|
|
|
![]() |